Faheem Hasnain News
Most Popular Faheem Hasnain Story
Facet seeks new bids after Biogen offer flops
With a pair of big investors turning their noses up at Biogen Idec's $17.50 per share offer for Facet Biotech, Biogen's bid to buy up its development partner bit the dust at midnight. But Facet was Read more...
Latest Headlines
- December 17, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
